{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:54:44Z","timestamp":1793501684415,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ghpjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.genhosppsych.2014.02.010","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T06:31:25Z","timestamp":1394001085000},"page":"388-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions"],"prefix":"10.1016","volume":"36","author":[{"given":"Preetha S.","family":"Kuppuswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Robert","family":"Takala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.genhosppsych.2014.02.010_bb0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/appi.ajp.2010.10020181","article-title":"Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment","volume":"168","author":"Chapman","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.genhosppsych.2014.02.010_bb0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.genhosppsych.2014.02.010_bb0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2012.03.001","article-title":"Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology","volume":"11","author":"Peery","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.genhosppsych.2014.02.010_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.genhosppsych.2014.02.010_bb0030","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.psym.2011.01.043","article-title":"Paraneoplastic encephalitis presenting as postpartum psychosis","volume":"52","author":"Yu","year":"2011","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1016\/j.genhosppsych.2014.02.010_bb0035","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.bp.111.092197","article-title":"Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis","volume":"199","author":"Barry","year":"2011","journal-title":"Br J Psychiatry"},{"issue":"9","key":"10.1016\/j.genhosppsych.2014.02.010_bb0040","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/sj.npp.1301312","article-title":"Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders","volume":"32","author":"Beneyto","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.genhosppsych.2014.02.010_bb0050","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1440-1819.2012.02324.x","article-title":"Electroconvulsive therapy can improve psychotic symptoms in anti-NMDA-receptor encephalitis","volume":"66","author":"Matsumoto","year":"2012","journal-title":"Psychiatry Clin Neurosci"},{"issue":"10","key":"10.1016\/j.genhosppsych.2014.02.010_bb0055","first-page":"38","article-title":"Glutamate involvement in schizophrenia: focus on N-methyl-d-aspartate receptors","volume":"13","author":"Javitt","year":"2006","journal-title":"Primary Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.psym.2010.11.010","article-title":"Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor","volume":"52","author":"Kung","year":"2011","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1752-1947-6-224","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis presenting with acute psychosis in a preteenage girl: a case report","volume":"6","author":"Maggina","year":"2012","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0070","doi-asserted-by":"crossref","unstructured":"Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis in psychiatry. Current Psychiatry Reviews 7(3)2011:189-193(5).","DOI":"10.2174\/157340011797183184"},{"issue":"12","key":"10.1016\/j.genhosppsych.2014.02.010_bb0075","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1007\/s00415-012-6561-z","article-title":"Anti-NMDA receptor encephalitis with associated catatonia during pregnancy","volume":"259","author":"McCarthy","year":"2012","journal-title":"J Neurol"},{"issue":"8","key":"10.1016\/j.genhosppsych.2014.02.010_bb0080","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0085","doi-asserted-by":"crossref","unstructured":"Kjaerby C, Broberg BV, Kristiansen U, Dalby NO. Impaired GABAergic inhibition in the prefrontal cortex of early postnatal phencyclidine (PCP)-treated rats. Cereb Cortex. 2013.","DOI":"10.1093\/cercor\/bht109"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0090","doi-asserted-by":"crossref","unstructured":"Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand 2013;(441 Suppl):1\u201347. http:\/\/dx.doi.org\/10.1111\/acps.12038.","DOI":"10.1111\/acps.12038"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0095","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1212\/WNL.0b013e3181f11dc1","article-title":"Pearls and oysters: electroconvulsive therapy in anti-NMDA receptor encephalitis","volume":"75","author":"Braakman","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0100","doi-asserted-by":"crossref","unstructured":"Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl). 2004;174(1):143-50. [Epub 2003 Dec 9].","DOI":"10.1007\/s00213-003-1673-x"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2014.02.010_bb0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0169-328X(98)00211-3","article-title":"Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b","volume":"61","author":"Watkins","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"10.1016\/j.genhosppsych.2014.02.010_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1254\/jjp.80.185","article-title":"Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression","volume":"80","author":"Ishihara","year":"1999","journal-title":"Jpn J Pharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0120","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bbr.2009.09.048","article-title":"Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors reverses sub-chronic PCP-induced deficits in the novel object recognition task in rats","volume":"207","author":"Damgaard","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0125","doi-asserted-by":"crossref","unstructured":"Lewis DA, Volk DW, Hashimoto T. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology (Berl). 2004;174(1):143-50. [Epub 2003 Dec 9].","DOI":"10.1007\/s00213-003-1673-x"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","article-title":"Cloned glutamate receptors","volume":"17","author":"Hollmann","year":"1994","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"10.1016\/j.genhosppsych.2014.02.010_bb0135","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.mp.4000529","article-title":"Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists","volume":"4","author":"Kim","year":"1999","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2014.02.010_bb0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0893-133X(95)00048-I","article-title":"Alpha 2 adrenergic agonists prevent MK-801 neurotoxicity","volume":"12","author":"Farber","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0893-133X(97)00127-9","article-title":"Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity","volume":"18","author":"Farber","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.genhosppsych.2014.02.010_bb0150","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.mp.4001087","article-title":"Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity","volume":"7","author":"Farber","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0920-9964(96)00024-2","article-title":"Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity","volume":"21","author":"Farber","year":"1996","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.genhosppsych.2014.02.010_bb0160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.mp.4000912","article-title":"Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity","volume":"7","author":"Farber","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpneuro0493","article-title":"A patient with the encephalitis associated with the NMDA receptor antibodies","volume":"3","author":"Sansing","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1196\/annals.1300.008","article-title":"Ann N Y. NMDA receptor hypofunction model of psychosis","volume":"1003","author":"Farber","year":"2003","journal-title":"Acad Sci"},{"issue":"1\u20132","key":"10.1016\/j.genhosppsych.2014.02.010_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(98)00926-3","article-title":"Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation","volume":"812","author":"Duncan","year":"1998","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.genhosppsych.2014.02.010_bb0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatr Res"},{"issue":"3","key":"10.1016\/j.genhosppsych.2014.02.010_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0235","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Acad Sci"},{"issue":"6","key":"10.1016\/j.genhosppsych.2014.02.010_bb0240","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/sj.npp.1300127","article-title":"Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine","volume":"28","author":"Takahat","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.genhosppsych.2014.02.010_bb0200","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-methyl-d-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.genhosppsych.2014.02.010_bb0205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/appi.ajp.162.3.626","article-title":"Memantine and catatonic schizophrenia","volume":"162","author":"Thomas","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.genhosppsych.2014.02.010_bb0210","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4088\/JCP.08m04935gry","article-title":"Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine","volume":"70","author":"de Lucena","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"10.1016\/j.genhosppsych.2014.02.010_bb0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1176\/appi.ajp.2011.11030471","article-title":"Anti-NMDA receptor encephalitis versus pediatric catatonia","volume":"168","author":"Dhossche","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2014.02.010_bb0220","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.yct.0000244236.72049.9e","article-title":"Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis","volume":"22","author":"Lee","year":"2006","journal-title":"J ECT"},{"issue":"2","key":"10.1016\/j.genhosppsych.2014.02.010_bb0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.neuropsych.11070151","volume":"24","author":"Mann","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834314000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834314000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T13:17:46Z","timestamp":1648473466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834314000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0163834314000607"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.02.010","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2014.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}